loading
전일 마감가:
$12.21
열려 있는:
$11.98
하루 거래량:
361.58K
Relative Volume:
0.81
시가총액:
$333.58M
수익:
$157.75M
순이익/손실:
$-29.73M
주가수익비율:
-10.60
EPS:
-1.16
순현금흐름:
$-21.00M
1주 성능:
-17.67%
1개월 성능:
-5.31%
6개월 성능:
-27.52%
1년 성능:
-43.00%
1일 변동 폭
Value
$11.87
$12.41
1주일 범위
Value
$11.87
$15.18
52주 변동 폭
Value
$8.04
$25.88

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
명칭
Arcturus Therapeutics Holdings Inc
Name
전화
(858) 900-2660
Name
주소
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
직원
176
Name
트위터
@ArcturusRx
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
ARCT's Discussions on Twitter

ARCT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
12.30 331.14M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-28 개시 Scotiabank Sector Outperform
2025-01-28 개시 BTIG Research Buy
2024-08-12 개시 Leerink Partners Outperform
2023-12-13 개시 Canaccord Genuity Buy
2023-07-24 개시 William Blair Outperform
2023-05-11 업그레이드 H.C. Wainwright Neutral → Buy
2022-11-14 재개 Wells Fargo Overweight
2022-11-10 다운그레이드 Robert W. Baird Neutral → Underperform
2022-11-03 업그레이드 Citigroup Neutral → Buy
2022-11-02 업그레이드 Barclays Underweight → Equal Weight
2022-08-10 다운그레이드 Raymond James Mkt Perform → Underperform
2022-07-19 재개 Cantor Fitzgerald Overweight
2022-05-11 업그레이드 Robert W. Baird Underperform → Neutral
2022-04-21 다운그레이드 Citigroup Buy → Neutral
2022-01-31 업그레이드 Raymond James Underperform → Mkt Perform
2021-08-12 다운그레이드 Raymond James Mkt Perform → Underperform
2021-08-11 다운그레이드 Goldman Neutral → Sell
2021-08-10 다운그레이드 Robert W. Baird Neutral → Underperform
2021-07-02 개시 Cantor Fitzgerald Overweight
2021-06-25 재개 Goldman Neutral
2021-06-21 다운그레이드 Barclays Equal Weight → Underweight
2021-06-04 재개 Robert W. Baird Neutral
2021-02-17 다운그레이드 B. Riley Securities Neutral → Sell
2021-01-19 다운그레이드 B. Riley Securities Buy → Neutral
2021-01-15 다운그레이드 B. Riley Securities Buy → Neutral
2021-01-07 개시 Wells Fargo Overweight
2020-12-29 다운그레이드 Barclays Overweight → Equal Weight
2020-12-29 다운그레이드 H.C. Wainwright Buy → Neutral
2020-12-29 다운그레이드 Raymond James Outperform → Mkt Perform
2020-12-29 다운그레이드 Robert W. Baird Outperform → Neutral
2020-12-23 다운그레이드 ROTH Capital Buy → Sell
2020-12-08 재확인 B. Riley Securities Buy
2020-12-07 재확인 B. Riley Securities Buy
2020-10-26 개시 Barclays Overweight
2020-10-06 개시 Citigroup Buy
2020-08-26 개시 Piper Sandler Overweight
2020-07-30 재개 ROTH Capital Buy
2020-07-16 개시 Raymond James Outperform
2020-07-13 개시 B. Riley FBR Buy
2020-06-09 다운그레이드 WBB Securities Buy → Hold
2020-02-11 개시 Robert W. Baird Outperform
2020-02-07 개시 Guggenheim Buy
2020-02-06 개시 Guggenheim Buy
2019-04-05 개시 H.C. Wainwright Buy
2018-09-20 업그레이드 WBB Securities Buy → Strong Buy
2018-01-22 개시 Chardan Capital Markets Buy
모두보기

Arcturus Therapeutics Holdings Inc 주식(ARCT)의 최신 뉴스

pulisher
01:14 AM

Is Arcturus Therapeutics Holdings Inc. stock overvalued or undervaluedSwing Trade Entry Points For Fast Growth - jammulinksnews.com

01:14 AM
pulisher
Aug 01, 2025

How does Arcturus Therapeutics Holdings Inc. compare to its industry peersBreakout Stocks Recommendation With Proven Results - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

High Growth US Tech Stocks To Watch In August 2025 - simplywall.st

Aug 01, 2025
pulisher
Jul 31, 2025

Is Arcturus Therapeutics Holdings Inc. a growth stock or a value stockRetirement Planning Review With Proven Results - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) Weighed On By Its Debt Load? - simplywall.st

Jul 31, 2025
pulisher
Jul 31, 2025

Why is Arcturus Therapeutics Holdings Inc. stock attracting strong analyst attentionBeginner Investor Report With Low Risk - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 23:05:26 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Sector ETF Data Correlates with Strength in Arcturus Therapeutics Holdings Inc.Investment Playbook for Growing Markets Shared - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Arcturus Therapeutics Holdings Inc. Sees Relief Buying After Extended DropQuick Gain Stock Watch With Indicators Reviewed - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Using R and stats models for Arcturus Therapeutics Holdings Inc. forecastingFree Real-Time Analysis With Entry Targets - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Price Floor Holding on Arcturus Therapeutics Holdings Inc. — Rebound PossibleSmart Investment Tips Gaining Popularity Among Analysts - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

How Arcturus Therapeutics Holdings Inc. stock performs during market volatilityCapital Growth Summary Over Five Years - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Arcturus Therapeutics Holdings Inc. Shows Risk Reward Favoring UpsideGrowth Focused Entry Plan Suggestions Issued - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Arcturus Therapeutics Holdings Inc. in the next 12 monthsEarnings Report Insights With Low Risk - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Arcturus Therapeutics Holdings Inc. stock perform well during market downturnsFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why Arcturus Therapeutics Holdings Inc. stock attracts strong analyst attentionTrading Volume Anomaly Summary and Insight - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

New York State Common Retirement Fund Sells 1,100 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Jul 28, 2025
pulisher
Jul 28, 2025

What are Arcturus Therapeutics Holdings Inc. company’s key revenue driversBreakthrough financial growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Arcturus Therapeutics Holdings Inc. stock price move sharplyBuild wealth steadily with proven strategies - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive Arcturus Therapeutics Holdings Inc. stock higher in 2025Unlock powerful trading strategies for gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Arcturus Therapeutics Holdings Inc. Stock Support and Resistance Levels You Should KnowFree Stock Market Swing Trading Strategies - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Is Arcturus Therapeutics Holdings Inc. Stock Overbought or Oversold RSI Indicator AnalysisMinimized Risk Maximum Return - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Arcturus Therapeutics Holdings Inc. stockInvest confidently with data-driven strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Is Arcturus Therapeutics Holdings Inc. a good long term investmentFree Investment Community - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Does Arcturus Therapeutics Holdings Inc. stock pay reliable dividendsOutstanding capital returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Arcturus Therapeutics Holdings Inc. stockExceptional trading performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Arcturus Therapeutics Holdings Inc. stock priceConsistent high-yield stocks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 - BioSpace

Jul 24, 2025
pulisher
Jul 24, 2025

Arcturus Therapeutics Holdings Inc. Stock Analysis and ForecastTriple-digit wealth increases - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Arcturus Therapeutics to Attend Upcoming Investor ConferencesJuly 23, 2025 - BioSpace

Jul 24, 2025

Arcturus Therapeutics Holdings Inc (ARCT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
자본화:     |  볼륨(24시간):